Natixis Advisors LLC lifted its position in Amdocs Limited (NASDAQ:DOX - Free Report) by 70.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 46,898 shares of the technology company's stock after acquiring an additional 19,306 shares during the quarter. Natixis Advisors LLC's holdings in Amdocs were worth $3,993,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Private Trust Co. NA lifted its holdings in Amdocs by 62.9% in the third quarter. Private Trust Co. NA now owns 303 shares of the technology company's stock worth $27,000 after acquiring an additional 117 shares during the last quarter. Brooklyn Investment Group acquired a new position in Amdocs during the 3rd quarter valued at approximately $28,000. Jones Financial Companies Lllp bought a new position in Amdocs during the 4th quarter worth $36,000. SBI Securities Co. Ltd. acquired a new stake in Amdocs in the fourth quarter worth $41,000. Finally, Global Retirement Partners LLC lifted its stake in Amdocs by 45.6% in the fourth quarter. Global Retirement Partners LLC now owns 559 shares of the technology company's stock valued at $48,000 after buying an additional 175 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors.
Amdocs Stock Performance
Shares of DOX traded up $1.55 during trading hours on Wednesday, reaching $91.97. 730,214 shares of the company's stock traded hands, compared to its average volume of 657,074. Amdocs Limited has a twelve month low of $74.41 and a twelve month high of $93.34. The business's fifty day simple moving average is $87.46 and its two-hundred day simple moving average is $87.23. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20. The firm has a market capitalization of $10.38 billion, a price-to-earnings ratio of 21.34, a P/E/G ratio of 1.47 and a beta of 0.68.
Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. Analysts predict that Amdocs Limited will post 6.21 earnings per share for the current year.
Amdocs Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Monday, March 31st will be given a $0.527 dividend. This represents a $2.11 dividend on an annualized basis and a yield of 2.29%. This is an increase from Amdocs's previous quarterly dividend of $0.48. The ex-dividend date is Monday, March 31st. Amdocs's dividend payout ratio is 48.72%.
Wall Street Analysts Forecast Growth
Separately, StockNews.com cut shares of Amdocs from a "strong-buy" rating to a "buy" rating in a report on Friday, February 28th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $101.20.
Get Our Latest Analysis on DOX
About Amdocs
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.